Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Quantitative evaluation of brain perfusion MRI with gadobutrol

Trial Profile

Quantitative evaluation of brain perfusion MRI with gadobutrol

Phase of Trial: Phase II

Latest Information Update: 07 Jul 2017

At a glance

  • Drugs Gadobutrol (Primary) ; Gadoterate-meglumine
  • Indications Brain cancer
  • Focus Diagnostic use
  • Most Recent Events

    • 05 Jul 2017 Status changed from not yet recruiting to recruiting.
    • 16 Mar 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top